Search

everythinglearnresearchcommunity

for

Search:↓

TNF-α blockers and IL inhibitors improve symptoms in most patients with severe scalp condition, but more research is needed.

JAK inhibitors show promise for treating skin diseases effectively and safely.

A girl with Crohn's disease developed hair loss from her medication, which improved with treatment but later returned.

Infliximab can cause SAPHO syndrome, which may improve with Spesolimab and methotrexate.

A young woman had a rare skin reaction to a medication for her joint disease, and a combination therapy improved her condition.

PRP may improve early ACL healing, but long-term effects are unclear.

Intralesional corticosteroids are best for mild alopecia areata, and DPCP is best for severe cases.

Foam corticosteroid covers as well as traditional forms.

Baricitinib effectively treats certain skin conditions but may have serious side effects.

The guideline recommends using specific drugs and surgery together for treating hidradenitis suppurativa effectively.

Janus kinase inhibitors reduce inflammation markers in severe alopecia areata patients.

Combining microdermabrasion with steroid injections improves hair regrowth in scalp alopecia areata.

A 13-year-old girl with various symptoms was successfully treated for autoimmune disease using the antibiotic co-trimoxazole.

Methotrexate treatment for rheumatoid arthritis has a serious infection rate of about two per 100 patient-years.

Combining hydroxychloroquine and pimecrolimus can effectively treat hair loss from discoid lupus.

Oral pulse steroids reduce TNF-α levels, improving alopecia areata.

Tofacitinib may effectively treat hair loss and improve symptoms in autoimmune conditions like alopecia areata and Sjögren's syndrome, but long-term treatment might be necessary.

Hair regrowth was achieved using 5-Fluorouracil and Bleomycin for scalp atrophy caused by corticosteroids.

The study created special nanoparticles that effectively deliver an anti-inflammatory drug to treat skin inflammation in psoriasis.

Adalimumab significantly improved symptoms and quality of life in two patients with Hidradenitis Suppurativa.

JAK-inhibitors for alopecia areata are generally safe with mostly mild side effects and a low rate of treatment withdrawal.

Early treatment with JAK inhibitors leads to better hair regrowth in acute alopecia areata.

Early use of infliximab in severe pediatric Crohn's disease can lead to significant improvement and remission.

Platelet-rich plasma (PRP) injections successfully treated a woman's steroid-resistant hair loss, causing hair to regrow within a month.

High-dose steroid pulse therapy effectively regrows hair in severe multifocal alopecia areata.

Tofacitinib significantly improved hair loss and lesions in a patient with overlapping autoimmune disorders.

The new cocrystal KET-PABA is a more effective and safe anti-inflammatory treatment for skin conditions in mice.

Tofacitinib may be an effective and safe treatment for adolescent alopecia areata.

Upadacitinib may effectively treat both alopecia universalis and Crohn's disease.

MR antagonists may improve skin health and wound healing, especially in aging.